VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Acrigen

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

Precision Gene Editing.

  • Biotech & therapeutics
  • Deeptech
Status
Operatingas of 2026-09-19
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 19 September 2026

About

At Acrigen, we believe that gene editing will revolutionize medicine and bring hope to millions of patients suffering from genetic diseases. We are developing Precision Gene Editing Systems to harness the power of CRISPR for use in human therapeutics.

Products

Other
Precision Gene Editing Systems
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy